Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CEP170 |
| Upstream (Parents) |
|---|
| (<<) AKT3 → CEP170 |
| (<<) CDH11 → CEP170 |
| (<<) CHSY1 → CEP170 |
| (<<) EFEMP2 → CEP170 |
| (<<) ELK3 → CEP170 |
| (<<) PLAU → CEP170 |
| (<<) RPIA → CEP170 |
| (<<) TCF4 → CEP170 |
| (<<) TIMP2 → CEP170 |
| (<<) TIMP3 → CEP170 |
| (<<) TUBA1A → CEP170 |
| (<<) TWIST1 → CEP170 |
| (<<) VIM → CEP170 |
| Downstream (Children) |
|---|
| CEP170 → ADCY9 (>>) |
| CEP170 → B3GNT2 (>>) |
| CEP170 → CCDC88A (>>) |
| CEP170 → CEND1 (>>) |
| CEP170 → CHST11 (>>) |
| CEP170 → CHST3 (>>) |
| CEP170 → CLEC2B (>>) |
| CEP170 → CYP1B1 (>>) |
| CEP170 → DUSP6 (>>) |
| CEP170 → EDNRA (>>) |
| CEP170 → EPHB4 (>>) |
| CEP170 → GALR3 (>>) |
| CEP170 → GNB5 (>>) |
| CEP170 → GPX7 (>>) |
| CEP170 → HEY1 (>>) |
| CEP170 → HIF1A (>>) |
| CEP170 → ITPR1 (>>) |
| CEP170 → MEF2A (>>) |
| CEP170 → MSN (>>) |
| CEP170 → PCDH7 (>>) |
| CEP170 → PIK3CG (>>) |
| CEP170 → PIK3R3 (>>) |
| CEP170 → PSORS1C2 (>>) |
| CEP170 → RHOQ (>>) |
| CEP170 → SOX2 (>>) |
| CEP170 → SPR (>>) |
